v3.20.1
Employee Benefit Plans (Tables)
 12 Months Ended
Feb. 01, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
The following table summarizes share-based compensation expense (in thousands):
Year Ended
February 1,
2020		February 2,
2019		February 3,
2018
Continuing operations:
     Cost of goods sold$13,759  $12,024  $6,646  
     Research and development157,054  108,762  52,127  
     Selling, general and administrative71,996  77,309  26,349  
Share-based compensation - continuing operations$242,809  $198,095  $85,122  
Discontinued operations:
      Cost of goods sold—  —  (11) 
      Research and development—  —  1,458  
      Selling, general and administrative—  —  120  
Share-based compensation - discontinued operations—  —  1,567  
Total share-based compensation$242,809  $198,095  $86,689  
Schedule of Nonvested Share Activity
A summary of restricted stock unit activity, which includes time-based and performance-based or market-based restricted stock units, is as follows (in thousands, except per-share amounts):
Time-BasedPerformance-BasedMarket-BasedTotal
Number of
Shares		Weighted-
Average
Grant Date
Fair Value		Number  of
Shares		Weighted-
Average
Grant Date
Fair Value		Number of
Shares		Weighted-
Average
Grant Date
Fair Value		Number of
Shares		Weighted-
Average
Grant Date
Fair Value
Balance at January 28, 20179,925  $10.52  313  $13.91  559  $11.80  10,797  $10.69  
Granted8,154  $15.33  406  [1]$14.49  409  [1]$15.14  8,969  $15.28  
Vested(5,653) $10.86  —  $—  —  $—  (5,653) $10.86  
Canceled/Forfeited(2,137) $11.95  (47) $13.99  (47) $14.71  (2,231) $12.05  
Balance at February 3, 201810,289  $13.84  672  $14.25  921  $13.14  11,882  $13.81  
Assumed upon acquisition [4]13,289  $21.02  —  $—  —  $—  13,289  $21.02  
Granted7,453  $19.95  340  [1]$21.12  351  [1]$21.36  8,144  $20.06  
Vested(8,827) $16.30  —  $—  (30) $13.08  (8,857) $16.28  
Canceled/Forfeited(3,159) $19.64  (64) $16.29  (64) $16.52  (3,287) $19.51  
Balance at February 2, 201919,045  $19.15  948  $16.58  1,178  $15.40  21,171  $18.82  
Assumed upon acquisition [4]1,341  $25.61  —  $—  —  $—  1,341  $25.61  
Granted9,340  $23.36  288  [2]$13.90  3,621  [3]$15.39  13,249  $20.98  
Vested(10,781) $20.01  (576) $13.90  (713) $11.62  (12,070) $19.23  
Canceled/Forfeited(3,661) $20.57  (149) $17.86  (173) $21.12  (3,983) $20.49  
Balance at February 1, 202015,284  $21.34  511  $17.71  3,913  $15.83  19,708  $20.15  

[1] Amounts represent the target number of restricted stock units at grant date. For awards granted to our executive officers, up to 200% of the target restricted stock units may vest if the maximum level for performance goals is achieved.
[2] Amount represents the number of restricted stock unit goal shares.
[3] Amount represents the target number of restricted stock units at grant date, including 824 TSR RSU shares and 2,797 VCA RSU shares.
[4] See “Note 3 - Business Combinations” for additional information.
Schedule of Stock Option Activity
Stock option activity under the Company’s stock option and stock incentive plans is included in the following table (in thousands, except for per share amounts):
Number of
Shares		Weighted-
Average
Exercise
Price
Balance at January 28, 201725,096  $12.61  
Granted—  $—  
Exercised(10,305) $12.38  
Canceled/Forfeited(3,019) $14.33  
Balance at February 3, 201811,772  $12.36  
Assumed upon acquisition*3,026  $11.85  
Granted—  $—  
Exercised(4,812) $10.93  
Canceled/Forfeited(362) $13.64  
Balance at February 2, 20199,624  $12.87  
Assumed upon acquisition*808  $9.20  
Granted—  $—  
Exercised(6,178) $12.67  
Canceled/Forfeited(37) $13.57  
Balance at February 1, 20204,217  $12.44  
Vested or expected to vest at February 1, 20204,217  
* See “Note 3 - Business Combinations” for more information.
Schedule of Outstanding Options and Exercisable Options Information, by Range of Exercise Prices
Outstanding options and exercisable options information by range of exercise prices as of February 1, 2020 was as follows:
Outstanding OptionsExercisable Options
Range of
Exercise Prices		Number of
Shares
(in thousands)		Weighted-
Average
Remaining
Contractual Term
(in years)		Weighted-
Average
Exercise Price		Number of
Shares
(in thousands)		Weighted-
Average
Exercise Price
$3.89  $10.31  678  5.26$8.06  654  $8.03  
$10.76  $10.76  1,272  3.23$10.76  1,272  $10.76  
$10.89  $14.35  1,145  5.10$13.65  1,062  $13.65  
$14.45  $15.87  966  3.57$15.58  965  $15.58  
$15.91  $22.27  156  4.20$16.99  129  $16.91  
Total4,217  4.18$12.44  4,082  $12.41  
Weighted Average Assumptions Used to Calculate Fair Value Awards
The following weighted-average assumptions were used for each respective period to calculate the fair value of common shares to be issued under the ESPP on the date of grant using the Black-Scholes option pricing model:
Year Ended
February 1,
2020		February 2,
2019		February 3,
2018
Employee Stock Purchase Plan:
Estimated fair value$7.06  $4.91  $6.03  
Expected volatility35 %33 %30 %
Expected term (in years)1.21.21.2
Risk-free interest rate1.8 %2.6 %1.6 %
Expected dividend yield1.0 %1.4 %1.1 %
The following weighted-average assumptions were used for each respective period to calculate the fair value of common shares to be issued under Total Shareholder Return performance awards on the date of grant using the Monte Carlo pricing model:
Year Ended
February 1,
2020		February 2,
2019		February 3,
2018
Total Shareholder Return Awards:
Expected term (in years)3.02.92.9
Expected volatility32 %35 %35 %
Average correlation coefficient of peer companies0.5  0.5  0.5  
Risk-free interest rate2.4 %2.5 %1.4 %
Expected dividend yield1.0 %1.1 %1.6 %
The following weighted-average assumptions were used for estimating the fair value of common shares to be issued under VCA RSUs on the date of grant using the Monte Carlo pricing model:
Year Ended
February 1,
2020
Value Creation Awards:
Expected term (in years)4.66
Expected volatility35 %
Risk-free interest rate1.8 %
Expected dividend yield1.0 %